SCHEMBL7946281

SCHEMBL7946281

COCCNCC1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.42
ADH1C P00326 1/20 0.42
ADH1A P07327 1/20 0.42
ADH4 P08319 1/20 0.42
ADH7 P40394 1/20 0.42
LMNA P02545 1/20 0.41
EPHX2 P34913 1/20 0.41
POLB P06746 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
CA9 Q16790 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2773094 0.89
SCHEMBL13450923 0.88 LMNA (0.50) ADH1BADH1CADH1AADH4ADH7
Hydrochloric Acid SCHEMBL4349285 0.87 SAT1 (0.47) TDP1SAT1ALDH1A1TSHRNPSR1
SCHEMBL628429 0.82 SIGMAR1 (0.41) LMNAEPHX2SMN1; SMN2EPHX1ALDH1A1
Hydrochloric Acid SCHEMBL1677339 0.80 SIGMAR1 (0.40) LMNAEPHX2SMN1; SMN2TDP1EPHX1
SCHEMBL3915205 0.80 ALDH1A1 (0.39) TDP1SAT1ALDH1A1TSHRNPSR1
SCHEMBL11594234 0.79 ADH1B (0.54) ADH1BADH1CADH1AADH4ADH7
SCHEMBL20179337 0.77 LMNA (0.34) LMNAEPHX2POLBSMN1; SMN2KDM4E
SCHEMBL16086929 0.77 SAT1 (0.55) LMNAEPHX2POLBSMN1; SMN2KDM4E
SCHEMBL629341 0.76 ALDH1A1 (0.51) EPHX2POLBSMN1; SMN2KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122028918-A TRIM7 inhibitors and uses thereof 沙塔克实验室有限公司 2026-05-12 CN disclosed
WO-2025042798-A1 TRIM7 INHIBITORS AND USES THEREOF SHATTUCK LABS, INC. (US) 2025-02-27 WO disclosed
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed